How many stocks are there of Fidia SpA?
The current number of stocks of Fidia SpA is 6.93 M undefined.
Fidia SpA Stocks 2024
Fidia SpA Stocks
6.93 M
Ticker
FDA.MI
ISIN
IT0001498481
WKN
589983
In 2024, Fidia SpA had 6.93 M outstanding stocks, a 0% change from the 6.93 M stocks in the previous year.
The Fidia SpA Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2023 | 6.93 |
| 2022 | 6.93 |
| 2021 | 5.11 |
| 2020 | 5.11 |
| 2019 | 5.11 |
| 2018 | 5.11 |
| 2017 | 5.11 |
| 2016 | 5.11 |
| 2015 | 5.11 |
| 2014 | 5.11 |
| 2013 | 5.11 |
| 2012 | 5.11 |
| 2011 | 5.11 |
| 2010 | 5.11 |
| 2009 | 5.11 |
| 2008 | 4.87 |
| 2007 | 4.76 |
| 2006 | 4.72 |
| 2005 | 4.54 |
| 2004 | 4.59 |
Fidia SpA shares outstanding IT0001498481 · 589983
The number of shares was Fidia SpA in 2023 — This indicates how many shares 6.932 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Fidia SpA earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Fidia SpA's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Fidia SpA’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Fidia SpA's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 4.59 M Aktien |
| 2005 | 4.54 M Aktien |
| 2006 | 4.72 M Aktien |
| 2007 | 4.76 M Aktien |
| 2008 | 4.87 M Aktien |
| 2009 | 5.11 M Aktien |
| 2010 | 5.11 M Aktien |
| 2011 | 5.11 M Aktien |
| 2012 | 5.11 M Aktien |
| 2013 | 5.11 M Aktien |
| 2014 | 5.11 M Aktien |
| 2015 | 5.11 M Aktien |
| 2016 | 5.11 M Aktien |
| 2017 | 5.11 M Aktien |
| 2018 | 5.11 M Aktien |
| 2019 | 5.11 M Aktien |
| 2020 | 5.11 M Aktien |
| 2021 | 5.11 M Aktien |
| 2022 | 6.93 M Aktien |
| 2023 | 6.93 M Aktien |
Fidia SpA Aktienanalyse
What does Fidia SpA do?
Fidia SpA is an innovation leader in the field of pharmaceutical manufacturing, based in Abano Terme, Italy. The company was founded in 1946 and has since become a global company that brings innovative and high-quality products to the market. It has branches in Europe, Asia, and North America, employing over 800 employees worldwide. Fidia specializes in the development and manufacturing of pharmaceuticals for the treatment of joint diseases and injuries, as well as products for hyaluronic acid treatment. The company is focused on four main business areas: pharmaceuticals, medical devices, diagnostics, and research & development. In the pharmaceutical division, Fidia offers a wide range of products for the treatment of joint diseases and injuries. These include Hyafilia, an injectable product for the treatment of knee osteoarthritis, and Tricosaccaride, a topical product for the treatment of hair loss. Fidia also has a promising pipeline of drugs for various conditions, including osteoarthritis and arthritis. In the medical devices division, Fidia offers products for hyaluronic acid treatment. Hyaluronic acid is a natural substance that is present in the body and plays an important role in the restoration and maintenance of joint and tissue function. Fidia produces hyaluronic acid preparations in various concentrations and sizes for the treatment of knee osteoarthritis, shoulder injuries, and other joint diseases. The third main business area of Fidia includes diagnostics. The company offers a wide range of diagnostic products, including the ELISA method for measuring antibodies in blood and urine samples, as well as the latex agglutination test for detecting proteins in biological samples. Finally, Fidia is also very active in the field of research & development. The company invests continuously in the research and development of new products to provide its customers with innovative and effective solutions. Fidia has formed several partnerships with leading companies in the industry to enhance its research efforts and strengthen its market position. Fidia has earned a reputation in the industry as a reliable and innovative manufacturer of pharmaceuticals, medical devices, and diagnostics. The company aims to deliver high-quality products with high efficacy to its customers. With its wide range of products and leading research efforts, Fidia is well-positioned to continue being a key player in the industry in the future. Fidia SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Fidia SpA's Shares Outstanding
Fidia SpA's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Fidia SpA’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Fidia SpA’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Fidia SpA’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Fidia SpA stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Fidia SpA are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Fidia SpA evolved in recent years?
The number of shares of Fidia SpA has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Fidia SpA as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Fidia SpA?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Fidia SpA pay?
Over the past 12 months, Fidia SpA paid a dividend of 0.2 EUR . This corresponds to a dividend yield of about 179.37 %. For the coming 12 months, Fidia SpA is expected to pay a dividend of 0 EUR.
What is the dividend yield of Fidia SpA?
The current dividend yield of Fidia SpA is 179.37 %.
When does Fidia SpA pay dividends?
Fidia SpA pays a quarterly dividend. This is distributed in the months of June, June, June, August.
How secure is the dividend of Fidia SpA?
Fidia SpA paid dividends every year for the past 0 years.
What is the dividend of Fidia SpA?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Fidia SpA located?
Fidia SpA is assigned to the 'Industry' sector.
Wann musste ich die Aktien von Fidia SpA kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Fidia SpA from 7/5/2017 amounting to 0.2 EUR, you needed to have the stock in your portfolio before the ex-date on 7/3/2017.
When did Fidia SpA pay the last dividend?
The last dividend was paid out on 7/5/2017.
What was the dividend of Fidia SpA in the year 2023?
In the year 2023, Fidia SpA distributed 0 EUR as dividends.
In which currency does Fidia SpA pay out the dividend?
The dividends of Fidia SpA are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Fidia SpA
Our stock analysis for Fidia SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fidia SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
